At A Glance
Healthcare marketers are spending record amounts on pharma advertising, but most still can't connect campaign exposure to prescribing outcomes. This article explains why fragmented data, identity, and measurement systems break the link between patient (DTC) and healthcare professional (HCP) audiences, and the infrastructure that closes that gap.Originally published in AdExchanger
Key takeaways
- Pharma digital ad spend is tracking between $22 billion and $26 billion in 2026, yet most brands still can’t connect ad exposure to prescribing behavior.
- DTC and HCP teams need to agree on a shared measurement framework before a campaign launches, not after, so performance can be judged on one standard.
- Experian’s identity infrastructure keeps DTC and HCP data governed separately through two distinct paths while still making cross-audience measurement possible.
- Experian’s Audience Engine connects audience building to activation, giving teams access to premium publisher inventory and a marketplace of 19+ verified health data partners.
Healthcare marketing teams are spending more than ever. Pharma digital ad spend is now tracking between $22 billion and $26 billion in 2026, with connected TV (CTV) overtaking search as the most noticed healthcare ad channel. Yet most brands still can’t draw a straight line from campaign exposure to a filled prescription.
The problem isn’t budget or creative. It’s a structural gap in how healthcare marketers connect data, identity, and measurement across patient (DTC) and healthcare professional (HCP) audiences.
That gap is widening as campaigns grow more complex. A brand running a simultaneous patient (DTC) push and healthcare professional (HCP) engagement program is running two disconnected programs with different data sources, identity schemas, agency relationships, and definitions of success. When a patient sees a CTV ad and their cardiologist receives a targeted digital engagement the same week, almost no brand can confirm that those two exposures happened, let alone measure their combined effect on prescribing behavior.
Why is data fragmentation becoming a bigger challenge for healthcare marketers?
Data fragmentation is becoming a bigger challenge for healthcare marketers because the accuracy pharma brands are paying for in digital media doesn’t match what most measurement stacks can deliver. As pharma shifts spend from linear television to digital channels, the expectation of accuracy comes with it. Brands can no longer accept “we reached the right demographic” as a measurement answer when they are paying programmatic CPMs and expecting outcomes measured in script lift.
The typical healthcare marketer is working with three or four disconnected data environments. Consumer data lives in one place. Claims and National Provider Identifier (NPI) records live in another. Media reporting from the agency is in a third. Analytics and measurement are downstream of all of them, often running on a different timeline. Each handoff introduces the potential for data loss, and those losses compound across a campaign flight.
This creates a reporting picture that tells you what happened in each channel but not what worked across them. That distinction matters enormously when the goal isn’t impressions but activation, adherence, or prescribing behavior.
The missing layer in pharma marketing. Watch our Q&A
Does fixing healthcare data fragmentation mean merging DTC and HCP data together?
No, merging DTC and HCP data together isn’t the answer to healthcare data fragmentation. Healthcare data environments have strict governance requirements, and the separation of DTC and HCP data is both a regulatory and a strategic necessity. Merging DTC and HCP data into a single undifferentiated pool is not a goal worth pursuing.
What healthcare marketers actually need is a shared infrastructure that lets disparate data environments speak a common language without eliminating the boundaries between them. Three elements make that possible:
Experian’s identity infrastructure is built on this principle, acting as a neutral, interoperable workflow layer. For DTC audiences, that means high-fidelity tokenized matching that preserves accuracy from onboarding through activation and into partner-enabled measurement. For HCP audiences, it means deterministic NPI-based resolution using verified professional attributes including specialty, practice location, and professional address. These are two distinct identity paths, governed to keep DTC and HCP data separate while enabling measurement across both.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
What does a connected view of DTC and HCP audiences look like in healthcare marketing?
A connected view means DTC and HCP audiences in healthcare marketing runs on identity workflows matched to what each requires, deterministic resolution for HCPs and high-fidelity matching for DTC, with both feeding into shared measurement instead of siloed reporting. Building this kind of connected infrastructure isn’t a one-quarter initiative, but three questions show you where your program stands today.
Why is infrastructure the foundation for durable healthcare marketing programs?
Infrastructure is the foundation for durable healthcare marketing programs because it’s what lets audience planning, activation, and measurement function as one connected system instead of three separate handoffs that break down under pressure. As healthcare marketing gets more competitive, regulated, and measurable, that connected system is what keeps campaigns from starting over each time.
A connected view of DTC and HCP audiences in healthcare, with the proper guardrails in place, is a strategic decision about how your brand wants to compete. The technology and the partner ecosystem exist to make it real. The question is whether your marketing organization is structured to take advantage of it.
Ready to build a connected healthcare identity strategy?
Our team works with pharma brands to align identity, audience, and measurement across DTC and HCP programs. If you’re ready to close the gap between data and outcomes, let’s talk.
Click here to view Experian’s U.S. Consumer Data Privacy Notice.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
About the author
Kevin Dunn
Chief Revenue Officer, Experian
Kevin Dunn joins Experian Marketing Services with more than 20 years of leadership experience across marketing and advertising technology, most recently serving as Senior Vice President of Brands and Agencies at LiveRamp. In that role, he led growth across retail, CPG, travel, hospitality, financial services, and healthcare, overseeing new business, account expansion, and channel partnerships.
Kevin is known for building cohesive, accountable teams and leading with optimism, clarity, and a strong sense of shared purpose. His leadership philosophy centers on empowering people, driving positive outcomes for clients and fostering a culture where teams can grow, take smart risks, and succeed together.
FAQs
Most pharma brands can’t connect a CTV ad exposure to a prescribing decision because their DTC and HCP data runs through three or four disconnected environments: consumer data, claims and NPI records, agency media reporting, and downstream analytics. Each handoff between those systems introduces potential data loss, and those losses add up across a campaign flight, leaving brands with channel-level reporting instead of a connected view of what actually moved prescribing behavior.
Building a connected identity strategy doesn’t mean combining DTC and HCP data into one data set. Healthcare data environments carry strict governance requirements, so DTC and HCP data need to stay separate for both regulatory and strategic reasons. A connected identity strategy links those separate environments through interoperable workflows rather than merging them into one data set.
Experian helps pharma brands connect DTC and HCP measurement without merging their data by running two distinct, governed identity paths: high-fidelity tokenized matching for DTC audiences and deterministic NPI-based resolution for HCP audiences, built on verified professional attributes like specialty and practice location. That structure lets brands measure performance across both audiences while keeping the underlying data separate.
The difference between deterministic and probabilistic matching in healthcare marketing comes down to certainty: probabilistic matching can support large-scale DTC reach where some statistical estimation is acceptable, while HCP targeting calls for certainty that only deterministic matching, typically based on verified NPI data, can provide. As healthcare audiences get more specific, the cost of an unverified match rises, which is why HCP resolution leans deterministic.
If a healthcare marketing team’s audience strategy isn’t translating into activation, the first thing to check is whether those audience segments can actually reach live publisher inventory. A lot of audience development happens in a spreadsheet or analytics tool and then stalls at activation because the IDs never connect to real media. Experian’s Audience Engine builds audience creation, onboarding, and activation into one workflow, backed by a marketplace of 19+ verified health data partners.
Latest posts
London – 24 November, 2017 – Tapad, part of Experian, is the leader in cross-device marketing technology and continues to broaden its reach across EMEA. The business today reported a 20 percent growth in the scope of its regional device graph, a data set used by organisations to map consumers to their devices, enabling better, more personalised cross-device marketing. This news complements Tapad’s recent expansion of its UK team with the hire of experienced solutions engineer, Davide Rosamilia. As the demand for cross-device technology solutions continues to grow around the globe, coupled with the emergence of regulations such as Europe’s General Data Protection Regulation (GDPR), Tapad is committed to offering suppliers the greatest level of insight without compromising consumer privacy. Since Tapad started licensing its proprietary Tapad Device GraphTM just over a year ago, demand for the company’s technology has experienced significant growth. New supply partnerships and proactive data sourcing have also meant an increase in devices across key markets, which contribute to the overall 20 percent growth of the EMEA device graph, including a 44 percent increase in the U.K., 47 percent in France, and 85 percent in Germany. “We’re continuing to invest heavily in growing our regional device graph, allowing us to better meet the needs of EMEA marketers as they strive to reach individuals with greater precision in some of the most tightly regulated marketplaces worldwide,” said Tom Rolph, VP EMEA, Tapad. “This year, we have also welcomed 10 new data suppliers whom we’ve helped to increase cross-device amplification, attribution and audience extension, helping to further set us apart in the marketplace and successfully expand our EMEA presence.” Available around the world, the Device Graph provides access to Tapad’s globally compliant and privacy-safe datasets across EMEA, APAC and the U.S., and offers deeper knowledge of consumer preferences, purchase intent, and conversion behaviors. “Tapad has shown a unique ability to adapt to the nuances of the local EMEA market and display impressive growth without sacrificing dedication to privacy,” said Alistair Hill, CEO and Co-founder at On Device Research. “When we started vetting technology vendors, we needed to be sure that we selected a partner that could offer compliant and privacy-safe datasets to operate within our stringent data standards. Tapad’s probabilistic solution offered us greater scale, greater device reach, and increased engagement without compromising on privacy.” Contact us today
The Tapad Device Graph™ Will Expand Sizmek’s Cross-Device Reach and Improve the Efficiency and Precision of Digital Advertising NEW YORK, November 16, 2017 — Tapad, part of Experian and a leader in cross-device marketing technology, today announced a new global partnership with Sizmek, the largest independent buy-side advertising platform delivering impressions that inspire. By integrating the Tapad Device Graph™, Sizmek will enhance its AI-powered predictive capabilities to deliver accurate, cross-device messaging at global scale in a privacy-safe environment. Combined with Sizmek’s existing data enablement, creative optimization and media execution capabilities, the proprietary Tapad Device Graph improves the efficiency and precision of digital advertising by accurately matching people and devices. This enables advertisers to get a clear view of individual customer journeys, achieve scale without compromising on efficiency, and uncover new opportunities for conversion. Sizmek’s customers will have access to Tapad’s globally compliant and privacy-safe datasets across the Americas, EMEA, and APAC. With deeper knowledge of consumer preferences, purchase intent and conversion behaviors, Sizmek and its customers are able to enhance advertising strategies including cross-device audience identification and more. “Tapad is known for their strong cross-device capabilities, and their offering is an excellent addition to our growing program for best-of-breed data and measurement partners” says Mike Caprio, Sizmek’s Chief Growth Officer. “For our customers, this partnership will add further people-based marketing precision and reach to our comprehensive offerings around creative optimization, data enablement and media execution.” This partnership comes at a time of a massive shift in the marketing technology industry. Companies like Tapad and Telenor, as well as Rocket Fuel and Sizmek, are joining forces to adopt those technologies that are most efficient and accurate at reaching consumers at scale in a personalized and non-intrusive way. The combination of Tapad and Sizmek’s offerings will provide international marketers with exceptional resources to lead a more cost effective and results driven campaign. Contact us today
The Tapad Device Graph™ increases Throtle’s amplification by 475 percent. NEW YORK, Nov. 1, 2017 /PRNewswire/ — Tapad, now a part of Experian, the leader in cross-device marketing technology, today announced a partnership with Throtle, a leading data onboarding company. The Tapad Device Graph™ will enhance Throtle’s best-in-class onboarding capabilities by providing accurate and privacy-safe cross-device reach as well as precise audiences at scale. In partnership with Tapad, Throtle will deterministically link its services to a corroborated individual with hundreds of targeting attributes. This linkage allows Throtle to offer true cross-device identity management and identity resolution services to accompany its robust onboarding capabilities. Throtle will also work with Tapad to validate its device graph, building larger, more comprehensive audience segments. To date, the Tapad Device Graph™ has connected 61 percent of Throtle IDs to related ones in the graph, with an average amplification rate of 475 percent for Throtle’s IDs, or 4.8 new IDs per each of Throtle’s. Throtle has also seen its overall match rates involving Tapad’s identity insights rise an average of 15 percent since the inception of the partnership. More specifically, Tapad’s mobile advertising IDs (MAIDs) have increased Throtle’s in-app identity inventory by 35 percent. “Tapad has proven to be a trusted source for cross-device matching and has a tremendous reputation in the advertising and marketing technology industries for delivering superior precision and scale with the utmost dedication to privacy,” says Paul Chachko, CEO, Throtle. “Since we first began our test phase, and continuing through to this day, Tapad has met and exceeded our expectations for what a partner should be.” With Tapad’s strong commitment to precision and accuracy, Throtle was confident that this partnership would prove to be the right choice for the strategic expansion of its platform. Not only does Tapad deliver in-depth insights, parsing deterministic from probabilistic linkages, but its pool of device-level touchpoints enables Throtle to increase scale without seeing a decline in precision. For more information about the Tapad Device Graph™, or to request a demo, visit https://www.experian.com/marketing/consumer-sync About TapadTapad Inc. is a marketing technology company renowned for its breakthrough, unified, cross-device solutions. The company’s signature Tapad Device Graph™ connects millions of consumers across billions of devices. The world’s largest brands and most effective marketers entrust Tapad to provide an accurate, privacy-conscious, and unified approach to connecting with consumers across screens. In 2015, Tapad began licensing the Tapad Device Graph™ and swiftly became the established gold-standard throughout the ad tech ecosystem. Tapad is based in New York and has offices in Boston, Chicago, Dallas, Detroit, London, Los Angeles, Miami, Oslo, San Francisco, Singapore, and Tokyo. Tapad’s numerous awards include: Forbes’ Most Promising Companies, Deloitte’s Technology Fast 500, Crain’s Fast 50, TMCnet Tech Culture Award, and Global Startup Award’s “Startup Founder of the Year”. In 2016, Tapad was acquired by the Telenor Group, one of the world’s largest mobile operators. About ThrotleThrotle is a data onboarding company focused on deterministic matching and identity resolution, empowering brands with true individual-based marketing. Our data centric onboarding approach guarantees the highest level of accuracy, scale, and responsiveness for our clients. For more information on Throtle, please visit, throtle.io. Contact us today